Title:
KRAS G12D INHIBITOR AND APPLICATIONS THEREOF IN MEDICINE
Document Type and Number:
WIPO Patent Application WO/2022/194066
Kind Code:
A1
Abstract:
Provided are a compound having KRAS G12D modulating activity, a preparation method for same, and a pharmaceutical composition comprising same.
Inventors:
WU HAO (CN)
CHEN XIAOPING (CN)
LU YUAN (CN)
XU RENQI (CN)
HUANG CHUANLONG (CN)
HE JIANGQI (CN)
WANG WEI (CN)
LI BOYAN (CN)
ZHAN BO (CN)
ZHANG YUNLAI (CN)
WANG DONG (CN)
WANG GUOJIAN (CN)
ZHAO ZHICHANG (CN)
ZHANG HONGBO (CN)
ZHOU XIAO (CN)
LAN HONG (CN)
WANG JIABING (CN)
DING LIEMING (CN)
CHEN XIAOPING (CN)
LU YUAN (CN)
XU RENQI (CN)
HUANG CHUANLONG (CN)
HE JIANGQI (CN)
WANG WEI (CN)
LI BOYAN (CN)
ZHAN BO (CN)
ZHANG YUNLAI (CN)
WANG DONG (CN)
WANG GUOJIAN (CN)
ZHAO ZHICHANG (CN)
ZHANG HONGBO (CN)
ZHOU XIAO (CN)
LAN HONG (CN)
WANG JIABING (CN)
DING LIEMING (CN)
Application Number:
PCT/CN2022/080545
Publication Date:
September 22, 2022
Filing Date:
March 14, 2022
Export Citation:
Assignee:
BETTA PHARMACEUTICALS CO LTD (CN)
International Classes:
C07D487/08; A61K31/4995; A61K31/517; A61P35/00; C07D239/72; C07D519/00
Domestic Patent References:
| WO2021041671A1 | 2021-03-04 | |||
| WO2021106231A1 | 2021-06-03 | |||
| WO2022042630A1 | 2022-03-03 | |||
| WO2022068921A1 | 2022-04-07 | |||
| WO2022105857A1 | 2022-05-27 | |||
| WO2017172979A1 | 2017-10-05 |
Download PDF: